Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Clin Microbiol Infect ; 25(6): 763.e5-763.e8, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30928562

ABSTRACT

OBJECTIVES: We characterized the first ceftazidime-avibactam-resistant KPC-producing-Klebsiella pneumoniae clinical isolate detected in Greece, before the introduction of ceftazidime-avibactam in clinical practice. METHODS: K. pneumoniae KP-90 was isolated from a hospitalized patient in Thessaloniki during a nationwide surveillance study conducted between 2014 and 2016. Antimicrobial susceptibility was tested against a panel of agents. Whole-genome sequencing (Ion Torrent TM platform) of the isolate was carried out to identify the acquired resistance genes and mutations that were associated with ceftazidime-avibactam resistance. RESULTS: The K. pneumoniae isolate belonged to multilocus sequence type ST258 and harboured blaKPC-23 as the only carbapenemase gene. The isolate had a minimum inhibitory concentration (MIC) of 16 mg/L to ceftazidime-avibactam and was highly resistant to imipenem, meropenem (MICs, 512 mg/L) and ceftazidime (MIC, >1024 mg/L). blaKPC-23 was detected on a Tn4401a transposon, located on a pKPQIL-type plasmid. A non-functional outer membrane protein OmpK35 and an OmpK36 variant that had been previously associated with K. pneumoniae isolates of ST258 were detected. Transformation studies with Escherichia coli TOP10 showed that KPC-23 offered similar carbapenem MICs as KPC-2 and KPC-3. However, KPC-23 conferred a four-fold higher ceftazidime MIC (>1024 mg/L), which in the presence of avibactam was reduced (>7-fold) to 8 mg/L, which is just within the limit of the susceptibility breakpoint. CONCLUSIONS: Ceftazidime-avibactam resistance in a KPC-23- producing K. pneumoniae clinical isolate was due to increased ceftazidime hydrolysis and was likely enhanced by OmpK35 porin deficiency.


Subject(s)
Anti-Bacterial Agents/pharmacology , Azabicyclo Compounds/pharmacology , Ceftazidime/pharmacology , Drug Resistance, Bacterial , Genome, Bacterial , Klebsiella Infections/microbiology , Klebsiella pneumoniae/genetics , beta-Lactamases/genetics , Drug Combinations , Genomics , Greece , Humans , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests , Whole Genome Sequencing , beta-Lactamase Inhibitors/pharmacology
2.
Ophthalmologe ; 113(7): 599-601, 2016 Jul.
Article in German | MEDLINE | ID: mdl-26458892

ABSTRACT

Idiopathic epiretinal membrane (iERM) is very rare in adolescent patients. The pathogenesis remains unclear although the role of hyalocytes is of major importance. The clinical features in young patients are different from those in older patients. We describe a case of iERM in a 15-year-old girl who presented with metamorphopsia of the right eye. This case report presents the basis for the decision for surgical treatment as well as the clinical features at follow-up examination 9 months after surgery.


Subject(s)
Epiretinal Membrane/diagnosis , Epiretinal Membrane/surgery , Vision Disorders/diagnosis , Vision Disorders/surgery , Adolescent , Female , Fluorescein Angiography , Follow-Up Studies , Humans , Postoperative Complications/diagnosis , Recurrence , Tomography, Optical Coherence , Visual Acuity , Vitrectomy
3.
Ophthalmologe ; 113(7): 606-8, 2016 Jul.
Article in German | MEDLINE | ID: mdl-26531293

ABSTRACT

Low grade endophthalmitis is usually a chronic indolent inflammation that may be misdiagnosed as noninfectious uveitis. Therefore, this form of endophthalmitis is often unsuccessfully treated with corticosteroids. We describe the case of a patient with low grade endophthalmitis caused by Propionibacterium acnes after cataract surgery. This case report presents the difficulties in establishing the diagnosis of this form of endophthalmitis as well as the benefits of a combined operative therapy with pars plana vitrectomy, intravitreal antibiotics and posterior capsulectomy for successful treatment in such cases.


Subject(s)
Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/microbiology , Lenses, Intraocular , Postoperative Complications/diagnosis , Postoperative Complications/microbiology , Propionibacterium acnes , Aged, 80 and over , Amikacin/therapeutic use , Combined Modality Therapy , Diagnosis, Differential , Endophthalmitis/therapy , Female , Gram-Positive Bacterial Infections/therapy , Humans , Postoperative Complications/therapy , Vancomycin/therapeutic use , Vitrectomy
4.
Int Angiol ; 30(1): 35-42, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21248671

ABSTRACT

AIM: Semapimod is an experimental drug that strongly inhibits macrophages and stimulates the cholinergic anti-inflammatory pathway. The aim of this study was to evaluate the effect of semapimod on experimentally-induced acute intestinal ischemia-reperfusion syndrome in rabbits. METHODS: The experimental protocol included 16 adult male White New Zealand rabbits divided into two equal groups, A and B. Animals were subjected to 150 min of intestinal ischemia, followed by 30 min of reperfusion. At 30, 90 and 150 min after the onset of ischemia the animals in group A received i.v. placebo (2 mg/kg; Cytokine PharmaSciences Inc, PA, USA) and those of group B received i.v. semapimod (2 mg/kg; Cytokine PharmaSciences Inc, PA, USA). Blood samples were taken for plasma measurements of tumor necrosis factor-a (TNF-a), interleukin 1ß (IL-1ß) and interleukin 6 (IL-6) at 0, 60, 120 and 180 min after the onset of ischemia. At the same time points, wedge intestinal biopsies were taken for histopathological evaluation of mucosal injury. All data were analyzed by the non-parametric Mann-Whitney test as appropriate. The power effect of Semapimod was evaluated by mixed between-within Anova statistical analysis. RESULTS: Measurements of TNF-a and IL-1ß levels showed significant differences between groups A and B at 120 min (P=0.004 and P=0.003 respectively) and at 180 min (P=0.001 and p<0.005 respectively). IL-6 values were lower in animals of group B but the differences were not significant. Intestinal mucosal injuries were significantly milder in animals of group B at 120 and 180 min CONCLUSION: Semapimod minimized intestinal mucosa injury and reduced the systemic inflammatory response during acute intestinal ischemia-reperfusion. Further studies are required to investigate the possible value of semapimod as a new pretreatment modality in acute vascular abdomen.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Gastrointestinal Agents/pharmacology , Hydrazones/pharmacology , Intestinal Mucosa/drug effects , Intestines/blood supply , Mesenteric Vascular Occlusion/drug therapy , Reperfusion Injury/prevention & control , Analysis of Variance , Animals , Anti-Inflammatory Agents/administration & dosage , Biopsy , Disease Models, Animal , Gastrointestinal Agents/administration & dosage , Hydrazones/administration & dosage , Inflammation Mediators/blood , Injections, Intravenous , Interleukin-1beta/blood , Interleukin-6/blood , Intestinal Mucosa/immunology , Intestinal Mucosa/pathology , Male , Mesenteric Vascular Occlusion/complications , Mesenteric Vascular Occlusion/immunology , Mesenteric Vascular Occlusion/pathology , Rabbits , Reperfusion Injury/etiology , Reperfusion Injury/immunology , Reperfusion Injury/pathology , Time Factors , Tumor Necrosis Factor-alpha/blood
5.
J Hosp Infect ; 76(1): 70-3, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20705205

ABSTRACT

We describe a hospital outbreak caused by colistin-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase in two distinct medical centres. Seven clinical isolates of K. pneumoniae exhibiting resistance to carbapenems were collected from patients with hospital-acquired infection. All isolates were phenotypically positive for carbapenemase activity but negative for metallo-beta-lactamase production. PCR analysis using specific primers for bla(KPC), bla(SHV), bla(TEM) and bla(CTX-M) demonstrated that all clinical strains of K. pneumoniae from hospital A and one isolate from hospital B were genetically related and carried bla(KPC-2) in addition to bla(SHV-12). In contrast, the remaining isolate carried bla(S)(HV-5) with bla(K)(PC-2) and yielded a different profile. These results indicate the clonal spread of KPC producers between hospitals as well as the acquisition of KPC genes by different K. pneumoniae strains. All isolates were resistant to carbapenems, beta-lactams, ciprofloxacin, aminoglycosides and colistin, but intermediately susceptible to tigecycline and susceptible to gentamicin. The infection was fatal in five cases. The emergence of colistin-resistant K. pneumoniae possessing bla(KPC)(-2) underscores the implementation of strict control measures to prevent their dissemination of these organisms in hospitals.


Subject(s)
Colistin/pharmacology , Cross Infection/epidemiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/drug effects , beta-Lactamases/biosynthesis , Adult , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/biosynthesis , Carbapenems/pharmacology , Cross Infection/microbiology , Cross Infection/mortality , DNA, Bacterial/genetics , Female , Genotype , Greece/epidemiology , Hospitals , Humans , Klebsiella Infections/microbiology , Klebsiella Infections/mortality , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/isolation & purification , Male , Middle Aged , Polymerase Chain Reaction
6.
Neurology ; 63(10): 1813-7, 2004 Nov 23.
Article in English | MEDLINE | ID: mdl-15557495

ABSTRACT

OBJECTIVE: To identify clinical factors contributing to the lateralization of mesiotemporal memory functions in epilepsy by using memory-activated fMRI. METHODS: Sixty patients aged 16 to 63 years with mesial temporal lobe epilepsy (MTLE) and 20 patients aged 16 to 60 years with extratemporal epilepsy (ETE) due to circumscribed epileptogenic lesions who consecutively underwent presurgical evaluation including continuous video-EEG monitoring and structural MRI examinations were examined. During memory fMRI, the activation condition consisted of retrieval from long-term memory induced by self-paced performance of an imaginative walk through the patient's hometown. On the basis of a previous study, memory lateralization was defined as typical if larger fMRI activation was in the mesiotemporal structures contralateral to the epileptic focus. RESULTS: There were 45 patients with MTLE who had typical memory lateralization (75%), whereas only 9 patients (45%) with ETE exhibited typical memory lateralization (p = 0.013). In MTLE patients, bilateral independent epileptiform discharges occurred more often in the atypical group than in patients with typical memory lateralization (p = 0.015). CONCLUSIONS: The fMRI lateralization of mesiotemporal visuospatial memory functions in patients with mesiotemporal lobe epilepsy (MTLE) is asymmetric: The larger activation usually appears contralateral to the side of the epileptogenic region. These findings occur more often in MTLE; in patients with extratemporal epilepsy, such type of asymmetry is not characteristic. In MTLE patients with bilateral independent epileptiform discharges, this type of asymmetry is also less frequent.


Subject(s)
Brain Mapping , Dominance, Cerebral/physiology , Epilepsy, Temporal Lobe/physiopathology , Magnetic Resonance Imaging , Memory/physiology , Adolescent , Adult , Anterior Temporal Lobectomy , Brain Neoplasms/complications , Brain Neoplasms/pathology , Electroencephalography , Epilepsies, Partial/physiopathology , Epilepsy, Temporal Lobe/complications , Epilepsy, Temporal Lobe/surgery , Female , Hemangioma, Cavernous/complications , Hemangioma, Cavernous/pathology , Hippocampus/pathology , Humans , Imagery, Psychotherapy , Male , Memory Disorders/etiology , Memory Disorders/physiopathology , Mental Recall/physiology , Middle Aged , Monitoring, Ambulatory , Preoperative Care , Space Perception , Video Recording , Visual Perception
7.
J Clin Microbiol ; 38(1): 456-7, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10618142

ABSTRACT

Roseomonas is a newly described genus of pink-pigmented, nonfermentative, gram-negative bacteria that have been recognized as a cause of human infections. Roseomonas fauriae is a species rarely isolated from clinical specimens. We report the first known case of peritonitis caused by R. fauriae in a patient receiving continuous ambulatory peritoneal dialysis.


Subject(s)
Gram-Negative Bacterial Infections/diagnosis , Kidney Failure, Chronic/complications , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/microbiology , Aged , Female , Humans , Kidney Failure, Chronic/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...